Effects of hypertonic (3%) saline in rats with circulatory shock and cerebral ischemia after heatstroke.
OBJECTIVE
To evaluate the effects of hypertonic (3%) saline in heatstroke rats with circulatory shock, intracranial hypertension, and cerebral ischemia.


METHODS
Urethane-anesthetized rats were exposed to a high ambient temperature of 42 degrees C until mean arterial pressure and local cerebral blood flow (CBF) in the corpus striatum began to decrease from their peak levels, which was arbitrarily defined as the onset of heatstroke. Control rats were exposed to 24 degrees C.


RESULTS
Extracellular concentrations of glutamate and lactate/pyruvate ratio (cellular ischemia markers), and glycerol (a cellular injury marker) in the corpus striatum of rat brain were assessed by intracerebral microdialysis methods. Striatal PO(2), temperature, and local CBF were measured with a combined OxyLite PO(2), thermocouple, and OxyFlo LDF, respectively. The values of mean arterial pressure, cerebral perfusion pressure, and striatal CBF and PO(2) in rats treated with 0.9% NaCl solution after the onset of heatstroke were all significantly lower than those in normothermic controls. In contrast, the values of intracranial pressure, brain temperature, and extracellular concentrations of glutamate, glycerol, and lactate/pyruvate in the corpus striatum were greater. Intravenous infusion of hypertonic (3%) saline solution either "0" time before the start of heat exposure or right after the onset of heatstroke significantly attenuated the heatstroke-induced arterial hypotension, intracranial hypertension, decreased cerebral perfusion, and cerebral ischemia and damage and resulted in prolongation of survival time.


CONCLUSIONS
Our results strongly suggest that the experimental heatstroke syndromes can be effectively prevented and treated by hypertonic saline.
Kuo
Jinn-Rung
JR
Section of Neurosurgery, Department of Surgery, Chi-Mei Medical Center, Yung-Kang City, Tainan, Taiwan.
Lin
Chia-Li
CL
Chio
Chung-Ching
CC
Wang
Jhi-Joung
JJ
Lin
Mao-Tsun
MT
D000818:Animals; D002545:Brain Ischemia / Q000097:blood / Q000188:drug therapy* / Q000209:etiology* / Q000503:physiopathology; D018883:Heat Stroke / Q000097:blood / Q000150:complications* / Q000503:physiopathology; D019586:Intracranial Hypertension / Q000188:drug therapy / Q000209:etiology; D051381:Rats; D017207:Rats, Sprague-Dawley; D012016:Reference Values; D012462:Saline Solution, Hypertonic / Q000627:therapeutic use*; D012769:Shock / Q000188:drug therapy* / Q000209:etiology*; D016019:Survival Analysis; D016896:Treatment Outcome
D012462:Saline Solution, Hypertonic